Form 6-K NOVARTIS AG For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Novartis (NVS) PT Raised to $108 at CFRA
April 23, 2024 1:11 PM EDTCFRA analyst Wan Nurhayati raised the price target on Novartis (NYSE: NVS) to $108.00 (from $105.00) while maintaining a Hold rating.
The analyst comments "We raise our target price by $3 to $108, implying a 2024 P/E of 15.4x, largely in line with the peer average. Novartis... More
